Information on the current situation, as of 24 January 2023
Following the changes to testing cost strategy with effect from 1 January 2023, numerous indicators are now only presented in weekly form. In a further modification, deaths are now only shown at the Switzerland and Liechtenstein level, for data protection reasons.
Development over time
Vaccinated people, Basel-Stadt, 21.12.2020 to 23.01.2023
Several vaccines for preventing COVID-19 are authorised in Switzerland and Liechtenstein. A booster vaccination with an mRNA vaccine from Moderna (Spikevax®) or Pfizer/BioNTech (Comirnaty®) and the Novavax (Nuvaxovid®) vaccine is recommended at the earliest four months after the last vaccine or after infection for everyone aged 16 or older. More information on the recommended vaccines and the time period between vaccines can be found on the FOPH website > Coronavirus: vaccination.
Information on adverse vaccination reactions (AVRs) is collected via Swissmedic’s spontaneous reporting system. Swissmedic reviews and evaluates the reported side effects. More details can be found on the Swissmedic website. The time frame desired can be selected with the slider below the graph.
Share of vaccinated people